Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Dec 9:11:1813-6.
doi: 10.2147/TCRM.S90488. eCollection 2015.

Docetaxel-related interstitial pneumonitis

Chung-Jen Wang  1 , Hou-Tai Chang  1 , Cheng-Yu Chang  1
Affiliations
Case Reports

Docetaxel-related interstitial pneumonitis

Chung-Jen Wang et al. Ther Clin Risk Manag. .

Abstract

Docetaxel (Taxotere(®)) is an agent that is indicated for the treatment of patients with locally advanced or metastatic non-small-cell lung cancer. In recent years, docetaxel-related interstitial lung disease (ILD) has been reported in several case series studies. The onset of ILD occurred ~10-20 days (median time: 18 days) after docetaxel administration. Here, we reported the case of a patient who had pulmonary toxicity of ILD within 3 days after using a relatively low-dose docetaxel administration. Although some articles have described patients who progressed to respiratory failure and needed intubation, this patient responded well to steroid treatment and discontinued docetaxel administration.

Keywords: docetaxel; interstitial lung disease.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Before chemotherapy. Notes: (A) A chest X-ray shows right lower lung consolidation and pleural effusion (black arrow). (B) A chest CT shows a soft tissue mass measured as 98.7×87.4×82.7 mm3 in the right lower lung field (white arrow) with central necrosis and lobulated pleural effusion (white arrow head). (C) A chest CT shows no interstitial lung disease or lymphangitis carcinomatosis. Abbreviation: CT, computed tomography.
Figure 2
Figure 2
3 days later following chemotherapy. Notes: (A) A chest X-ray shows increased interstitial lung markings bilaterally; the implanted port was placed at the right subclavian vein. (B) A chest CT shows diffuse ground glass opacity at the bilateral lung fields. Abbreviation: CT, computed tomography.
Figure 3
Figure 3
After steroid administration. Notes: (A) A chest X-ray shows no obviously increased lung marking, and the implanted port was placed at the right subclavian vein. (B) The repeated chest CT shows marked improvement in ground glass opacity. Abbreviations: CT, computed tomography; L, left side.
See this image and copyright information in PMC

References

    1. Eivind S, Gunhild H, Karsten G, et al. Lethal pneumonitis after docetaxel chemotherapy: case report and review of the literature. Acta Oncol. 2013;52:1034–1038. - PubMed
    1. Read WL, Mortimer JE, Picus J. Severe interstitial pneumonitis associated with docetaxel administration. Cancer. 2002;94:847–853. - PubMed
    1. Wang GS, Yang KY, Perng RP. Life-threatening hypersensitivity pneumonitis induced by docetacel (taxotere) Br J Cancer. 2001;85:1247–1250. - PMC - PubMed
    1. Chen YM, Shih JF, Perng RP, Tsai CM, Whang-Peng J. A randomized trial of different docetaxel schedules in non-small cell lung cancer patients who failed previous platinum-based chemotherapy. Chest. 2006;129:1031–1038. - PubMed
    1. Tamiya A, Naito T, Miura S, et al. Interstitial lung disease associated with docetaxel in patients with advanced non-small cell lung cancer. Anticancer Res. 2012;32:1103–1106. - PubMed

Publication types